Victoria Hodgkinson

Victoria_Hodgkinson3x2

Investigator

Executive Director, Canadian Neuromuscular Disease Registry


NMD4C Involvement: Pillar 2: Clinical Research, Pillar 3: Clinical Practice Research, Theme 5: Open Science

Email Victoria
LinkedIn profile

Biography

Dr. Hodgkinson is the Executive Director of the Canadian Neuromuscular Disease Registry, where she oversees the scientific management and coordination of national patient registries in neuromuscular disease. Her work involves management of the registry network, development and review of registry datasets, and research project design and scientific analyses. She is actively engaged in global collaborative projects to share data for common purposes, improve registry design and utility worldwide, and also acts as co-chair of the global TREAT-NMD SMA Registries group. Through this work she is involved in consensus building within Canada and globally. Before joining the CNDR, Victoria worked in business development with Innovate Calgary and the University of Calgary helping facilitate research partnerships between not-for-profits, industry, and academics.
Dr. Hodgkinson received her BA in Biology from Cornell University (NY, USA), and her Ph.D. in Biochemistry from the University of Missouri (MO, USA), where her work work focused on copper homeostasis in the central and peripheral nervous systems. Following her Ph.D. Victoria completed postdoctoral training in electrophysiology and calcium channel regulation at the University of Calgary. Throughout her training in both the US and Canada, Victoria also taught undergraduate and graduate level courses in biochemistry, cell biology, advanced microscopy, health research literacy, and epidemiology.


Recent Publications

Gauvreau, G, Behlim, T, Ng, P, Hodgkinson, V, Selby, K, Mah, JK et al.. Respiratory and Bulbar support in Spinal Muscular Atrophy Type I treated with Nusinersen. Can J Neurol Sci. 2025. 1-20 PMID:40357918

O'Connell, C, Rodrigue, X, Hodgkinson, V, Henley, K, Slayter, J, Aleman, A et al.. Thinking outside the box: A re-evaluation of Canadian recommended outcome measures in adult spinal muscular atrophy - report of a national consensus workshop. J Neuromuscul Dis. 2025. 22143602251336076 PMID:40356341

Peric, S, Ivanovic, V, Ashley, EJ, Esparis, B, Campbell, C, Wenninger, S et al.. International collaboration to improve knowledge on myotonic dystrophy type 2. J Neuromuscul Dis. 2024.11 (6)1229-1237 PMID:39973464

Côté, I, Hodgkinson, V, Nury, M, Bastenier-Boutin, L, Rodrigue, X. A Real-World Study of Nusinersen Effects in Adults with Spinal Muscular Atrophy Type 2 and 3. Can J Neurol Sci. 2025.52 (1)119-128 PMID:38532567

Stepanian, L, Laughlin, RS, Bacher, C, Izenberg, A, Hodgkinson, V, Dyck, A et al.. Chronic glucocorticoid management in neuromuscular disease: A survey of neuromuscular neurologists. Muscle Nerve. 2024.70 (1)52-59 PMID:38411028

See more on PubMed